Keith Marchiando - Oct 21, 2021 Form 4 Insider Report for Zivo Bioscience, Inc. (ZIVO)

Role
Chief Financial Officer
Signature
/s/ Keith Marchiando
Stock symbol
ZIVO
Transactions as of
Oct 21, 2021
Transactions value $
$0
Form type
4
Date filed
10/25/2021, 07:06 PM
Next filing
Aug 31, 2022

Derivative Securities (e.g., puts, calls, warrants, options, convertible securities)

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Underlying Class Amount Exercise Price Ownership Footnotes
transaction ZIVO Nonstatutory Stock Option to Purchase Common Stock Award $0 +288K $0.00 288K Oct 21, 2021 Common Stock 288K $5.50 Direct F1
* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id Content
F1 The option was issued pursuant to the 2021 Equity Incentive Plan and vests as follows: 25% upon acceptance of the grant, and 25% on each of the next three calendar anniversaries of the grant.